Merck MRK
NYSE MRK
$145.67 -3.61 (-2.42%)
As of: Sep 30, 2026 · 3:59 PM EDT

Merck (MRK) Non-Current Debt (2009 - 2026)

Updated

Merck's Non-Current Debt came in at $51.08 billion for Q2 2026, up 50.4% from $33.97 billion a year earlier and up 9.4% from the prior quarter.

Analysis

Merck (MRK) Non-Current Debt (2009 - 2026) Analysis & Trends

At the end of FY2025, Merck's Non-Current Debt was $46.75 billion, up 35.7% from FY2024.

  • Non-Current Debt has increased in each of the last three years, with a five-year compound annual growth rate of 13.0% (FY2020 to FY2025).
  • Going back by year, Non-Current Debt was $34.46 billion in FY2024 (+2.3%), $33.68 billion in FY2023 (+17.2%), $28.75 billion in FY2022 (-6.3%) and $30.69 billion in FY2021 (+21.0%).
  • The Q2 2026 figure represents the highest quarterly Non-Current Debt in data going back to Q2 2009.
  • Year-over-year, Non-Current Debt has increased for four consecutive quarters, with growth averaging 18.8% over the last eight quarters.
  • The fastest year-over-year change in Non-Current Debt over five years came in Q2 2026 (growth of 50.4%), and the weakest in Q3 2021 (a decline of 13.0%).
  • Business Quant data shows MRK's Non-Current Debt at $46.67 billion (Q1 2026), $46.75 billion (Q4 2025) and $39.97 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 37.34 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 62.48 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 51.08 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -108.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 51.86 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 23.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 60.50 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -
10 Bristol Myers Squibb 128.45 Bn 79.72 Bn 9.25 Bn 42.09 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 51.08 Bn
Mar 31, 2026 46.67 Bn
Dec 31, 2025 46.75 Bn
Sep 30, 2025 39.97 Bn
Jun 30, 2025 33.97 Bn
Mar 31, 2025 33.48 Bn
Dec 31, 2024 34.46 Bn
Sep 30, 2024 34.98 Bn
Jun 30, 2024 34.72 Bn
Mar 31, 2024 31.14 Bn
Dec 31, 2023 33.68 Bn
Sep 30, 2023 33.97 Bn
Jun 30, 2023 34.07 Bn
Mar 31, 2023 28.07 Bn
Dec 31, 2022 28.75 Bn
Sep 30, 2022 28.48 Bn
Jun 30, 2022 28.68 Bn
Mar 31, 2022 30.59 Bn
Dec 31, 2021 30.69 Bn
Sep 30, 2021 22.91 Bn
API Access

Merck Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=MRK&period=max&api_key=YOUR_API_KEY